Jun Xie

24PUBLICATIONS
122CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Digital electronic devicesMedical biochemistry - lipidsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 25, 2026
Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model.

|Jun 01, 2026
Control of lipid metabolism in chondrocytes is critical for skeletal growth.

|May 23, 2026
Long-term comparative analysis of AAV9-mediated gene replacement therapies for spinal muscular atrophy in mice.

|May 13, 2026
In vivo adenine base editing ameliorates Dravet syndrome phenotypes in a mouse model.

|Apr 14, 2026
In vivo base editing rescues liver pathophysiology and peroxisome dysfunction in a mouse model of Zellweger spectrum disorder.

Xin D Gao, Maximiliano Presa, Jordyn E Duby

|Oct 07, 2025
Transient rapamycin treatment avoids unwanted host immune responses toward AAV-delivered anti-HIV antibodies.

Sebastian P Fuchs, Paula G Mondragon, Rachel Zabizhin

Pageof 4

Frequent Collaborators

17 joint publications

Guangping Gao

5 joint publications

Dan Wang

5 joint publications

Phillip Wl Tai

4 joint publications

David R Liu